Ignite II

Training in Genomics & Precision Public Health
2023-09-07 - 2023-09-08 | Virtual
Thursday-Friday, September 7-8 | Online
Advances in genomics, data science, machine learning, and artificial intelligence are transforming practice. Next generation public health and medical workforces need to understand these developments and how they can be used to benefit population health.
Recognizing this challenge, Oak Ridge Institute for Science and Education (ORISE) is partnering with the Office of Genomics and Precision Public Health at the Centers for Disease Control and Prevention (CDC) to offer a free 2-day training event covering the latest developments in these fields: Current Issues in Genomics and Precision Public Health – Using Genomics and Big Data to Improve Population Health and Reduce Health Inequities.
Learn more and register on the event website.

The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health
2023-09-14 12:00 - 13:00 (America/New_York) | Virtual
Thursday, September 14 | 12-1 p.m. ET | Online
CDC Webinar: The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health: Where Are we Heading with Preemptive Pharmacogenomic Screening?
Individual variability in drug response efficacy or safety is becoming an increasing problem globally, given the growing population of older adults. Reasons for this variability include genomic factors, an area of study called pharmacogenomics. With genotyping technologies now widely available and decreasing in cost, implementing pharmacogenomics into clinical practice is widely viewed as an initial step in mainstreaming genomic medicine.
This seminar will review recent developments in the field of pharmacogenomics and the ongoing challenges in equitable translation of discoveries into clinical practice and public health programs.
Speaker:
Professor Sir Munir Pirmohamed, MB ChB (Hons), PhD, FRCP, FRCP(E), FFPM, FRSB, FBPhS, FMedSci
David Weatherall Chair of Medicine and National Health Service Chair of Pharmacogenetics
Director, Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine
Institute of Systems, Molecular and Integrative Biology (ISMIB)
University of Liverpool
Please note: registration is required. Visit the CDC Genomics & Precision Health event page to learn more and sign up.

NHGRI Division of Intramural Research Seminar
2023-09-21 14:00 - 15:00 | Virtual
Thursday, September 21 | 2 – 3 p.m. | Bethesda, MD & Online
The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
All seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available.
Speaker:
Brittany Adamson, Ph.D.
Assistant Professor, Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics
Princeton University
Hosts: Meru Sadhu and Annette Iturralde Guerrero

View past presentations, learn more about upcoming seminars, and register to attend on the NHGRI website.

Exploring the Evolution of Familial Disease to Today’s Possibility for Hereditary Cancer Prevention
2023-09-28 11:00 - 17:00 | Virtual
From Generations Past to Future Health: Exploring the Evolution of Familial Disease to Today’s Possibility for Hereditary Cancer Prevention
Thursday, September 28 | 11 a.m. ET | Online
Speakers: Dr. Oscar Lao, Principal Investigator at Institut de Biologia Evolutiva, and Dr. Brian Shirts, Associate Professor of Laboratory Medicine and Pathology, University of Washington
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

G2MC 7th International Conference
2023-10-02 - 2023-10-04 | Virtual
October 2-4, 2023 | Online & Geneva, Switzerland
The Global Genomic Medicine Consortium (G2MC) 7th International Conference will be held October 2-4, 2023 in Geneva, Switzerland. For those unable to attend in person, we will also be incorporating virtual sessions.
The theme of the 2023 conference is connecting with governing bodies and organizations, particularly LMICs, to enhance collaborations to ultimately influence genomic medicine implementation worldwide.
Visit the conference website for more information.

Cystic Fibrosis: Precision Treatment of a Rare Monogenic Disease
2023-10-04 15:00 - 17:00 | Virtual
Wednesday, October 4 | 3 – 5 p.m. ET | Online
Join the UNC Program for Precision Medicine in Healthcare (PPMH) for Cystic Fibrosis: Precision Treatment of a Rare Monogenic Disease, a free virtual mini-symposium. At this interactive event, participants will engage in discussion with leading precision nutrition researchers at UNC.
Presentation: Developing small-molecule therapies to rescue rare CFTR variants
Speaker:
Rhianna Lee, PhD
Postdoctoral associate, Duke University, Cell Biology Department
Presentation: Personalized medicine, the fight against antibiotic resistance, and precision dosing
Speaker:
Gauri Rao, PharmD
Associate Professor, USC Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California
Adjunct Associate Professor, UNC Eshelman School of Pharmacy, UNC Chapel Hill
Presentation: From Data to Dosing: Streamlining CF Modulator Choices
Speaker:
Michael Adams, MD
Clinical Instructor, Division of Genetics & Metabolism, Department of Pediatrics, UNC School of Medicine
Learn more and register on the PPMH website.

PRS for the PCP: Evaluating polygenic risk scoring in primary care with clinical trials
2023-10-18 15:00 - 16:15 | Virtual
Wednesday, October 18 | 3 – 4:15 p.m. ET | Online

Beginning September 2022, NHGRI will host a new seminar series based on its Genomic Innovator Award Program, which supports innovative work by early-career genomics investigators who are part of consortia or other team-science efforts. Each seminar will feature an early-career researcher and an established researcher. Their presentations will cover specific topics that showcase the creative ways that early-career investigators are accelerating genomics research.
Each seminar will include two speakers (each giving 20-minute talks) followed by a moderated Q&A session.
This seminar will be presented by speakers:
Katrina A.B. Goddard, Ph.D.
Director, Division of Cancer Control and Population Sciences
National Cancer Institute
Jason L. Vassy, M.D., MPH, M.S.
Associate Professor of Medicine; Clinician-Investigator; Founding Member of Precision Population Health
Harvard Medical School; Veterans Affairs (VA) Boston Healthcare System and Brigham and Women’s Hospital; Ariadne Labs
Please note: registration is required. Learn more and register on the Genomic Innovator Seminar Series website.

Challenges, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program
2023-10-26 07:00 - 08:00 | Virtual
Challenges, Insights and Outcomes of a Clinically Integrated Multi-omic Rare Disease Program, RDNow, for Individuals Who Remain Undiagnosed After Clinical Genomic Sequencing
Thursday, October 26 | 7 a.m. ET | Online
Speaker: Dr. Michelle de Silva
Michelle is an associate genetic counselor with a PhD in molecular genetics. She is an experienced medical researcher and has managed several multidisciplinary research centres at the University of Melbourne, while also working as the program manager of the Rare Disease Flagship and RDNow Program at Murdoch Children’s Research Institute in Melbourne.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

Cost-Effectiveness Analysis in Public Health Genomics & Precision Health
2023-10-26 11:00 - 12:00 | Virtual
Thursday, October 26 | 11 a.m. – 12 p.m. ET | Online

CDC Webinar – Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings, Methodologic Issues, and the Path Forward
Speaker:
David Veenstra, PhD
Professor in the Department of Pharmacy and the Comparative Health Outcomes, Policy & Economics (CHOICE) Institute
University of Washington
Please note: registration is required. Visit the CDC Genomics & Precision Health event page to learn more and sign up.

NHGRI Division of Intramural Research Seminar
2023-10-30 14:00 - 15:00 | Virtual
Monday, October 30 | 2 – 3 p.m. | Bethesda, MD & Online
The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
All seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available.
Speaker:
Matthew Hurles, FMedSci, FRS
Director, Wellcome Sanger Institute
Co-Host:
Eric Green, NHGRI Office of the Director
View past presentations, learn more about upcoming seminars, and register to attend on the NHGRI website.

FDA Webinar | Proposed Rule: Medical Devices; Laboratory Developed Tests
2023-10-31 13:00 - 14:00 | Virtual
Proposed Rule: Medical Devices; Laboratory Developed Tests
Tuesday, October 31 | 1 p.m. ET | Online
The U.S. Food and Drug Administration (FDA) will host a public webinar to provide information on the proposed rule regarding Laboratory Developed Tests (LDTs). During the webinar, the FDA will:

Provide an overview of the rulemaking proposal to amend the FDA’s regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act including when the manufacturer of the IVD is a laboratory.
Describe the proposed phaseout of FDA’s general enforcement discretion approach to LDTs.
Host a Q&A session based on questions that have been submitted prior to the webinar at CDRHWebinars@fda.hhs.gov. Questions will not be taken during the live webinar. All questions are due by October 23, 2023, to be considered for the discussion.

Registration is not required. To learn more and access the Zoom webinar details, visit the event page.

ASHG Annual Meeting
2023-11-01 - 2023-11-05 | Walter E. Washington Convention Center
November 1-5 | Washington, DC
The American Society for Human Genetics (ASHG) annual meeting will take place November 1-5, 2023, in Washington, D.C.
Visit the meeting website for more information.

Carolina Seminar Series | Empowering Trust: Insights from Community Engagement Initiatives
2023-11-08 16:00 - 17:15 | Virtual
Empowering Trust: Insights from Community Engagement Initiatives
Wednesday, November 8 | 4 p.m. ET | Online
Speaker: Mya Roberson, MSPH, PhD,
Assistant Professor, Department of Health Policy and Management, UNC-Chapel Hill
Community engagement continues to be a critical component in genomic medicine and precision health research where the overall goal is to improve health outcomes of communities. The translation of findings into practice and implementation depends heavily on stakeholder engagement throughout the research process. This seminar session will explore insights gained from various engagement strategies and how appropriate incorporation of community stakeholders’ insights can improve the relevance and usefulness of genomic medicine and precision health research. Speakers and panelists will share their perspectives on community engagement, discuss strategies to address the gaps that remain and how to address the challenge of hesitancy among some communities.
To learn more and register, visit the UNC events page.
Please note: Registration is required for this seminar.

Transdisciplinary Conference for Future Leaders in Precision Public Health
2023-11-09 10:00 - 17:30 | Virtual
Transdisciplinary Conference for Future Leaders in Precision Public Health
Thursday, November 9 | 10 a.m. ET | Online
The UNC Eshelman School of Pharmacy’s Precision Public Health Network is sponsoring this free, virtual conference with expert speakers, a breakout networking session, and a virtual poster session. A follow-up workshop will be held on Thursday, November 16, from 3-6 p.m. ET to discuss priority-setting for the field.
For more information and to register, visit the event page.
Please note: Registration is required.

Precision Medicine and Immunotherapy: The new frontiers in cancer care?
2023-11-10 11:00 - 12:00 | Virtual
Precision Medicine and Immunotherapy: The new frontiers in cancer care?
Friday, November 10 | 11 a.m. ET | Online
Speaker: Ugwuji Maduekwe, MD, MMSc, MPH
Dr. Maduekwe will present an exploration of the dispersion of new therapies in the care of cancer that are inequitably distributed and solutions to closing these gaps.
To learn more and register, visit the webinar page.
Please note: Registration for the full webinar series is required.

NASEM | Roundtable on Genomics and Precision Health - Strategic Plan Reflection on the Roundtable's Work Since 2020
2023-11-15 12:00 - 13:15 | Virtual
Roundtable on Genomics and Precision Health – Strategic Plan Reflection on the Roundtable’s Work Since 2020
Wednesday, November 15 | 12 p.m. ET | Online
The Roundtable on Genomics and Precision Health will host a virtual event to highlight the work of the Roundtable since the adoption of its strategic plan in 2020. Speakers will provide their perspectives on the goals and key takeaways heard from workshop and event speakers as well as look ahead to what comes next. Public events include:

Improving Diversity of the Genomics Workforce: A Workshop (2021)
Views & Voices: Reporting Genetics and Genomics (2022)
Realizing the Potential of Genomics across the Continuum of Precision Health Care: A Workshop (2022)
Next-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth: A Workshop (2023)

The event will be accessible via webinar. Learn more and register on the event page.

Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation
2023-11-30 12:00 - 13:00 | Virtual
Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation
Thursday, November 30 | 12-1 p.m. ET | Online
Speakers: Dr. Stephen F. Kingsmore, president/CEO of Rady Children’s Institute for Genomic Medicine (RCIGM)
To learn more and register, visit the CDC event page.
Please note: Registration is required for this webinar.

Carolina Seminar Series | Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science
2023-12-06 16:00 - 17:15 | Virtual
Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science
Wednesday, December 6 | 4 p.m. ET | Online
Speakers: Caitlin Allen, PhD, MPH
Assistant Professor, Medical University of South Carolina
Elizabeth Mayer-Davis, PhD, RD
Boshamer Distinguished Professor of Nutrition and Medicine, UNC-Chapel Hill
As technologies and health interventions expand at a rapid rate in healthcare, many providers and patients desire quick and efficient incorporation of these new offerings in to practice. The field of implementation science can be critical in studying the barriers and facilitators to bring options previously available only in the research realm to the clinic. The design and development of health interventions are increasingly informed by implementation science theories, models, and frameworks to emphasize diverse reach and improve adoption and increase health equity in under served and marginalized communities. By testing new clinical offerings with implementation science methodologies, we can improve the quality of health practices for all patients while promoting equity and inclusion and ensuring that the availability of novel clinical offerings does not exacerbate existing health disparities.
To learn more and register, visit the UNC events page.
Please note: Registration is required for this seminar.

NHGRI Division of Intramural Research Seminar
2023-12-14 14:00 - 15:00 | Virtual
Thursday, December 14 | 2 – 3 p.m. | Bethesda, MD & Online
The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
All seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available.
Speaker:
Marius Wernig, M.D., Ph.D.
Professor in the Departments of Pathology and Chemical and Systems Biology
Stanford University School of Medicine
Hosts: William Gahl, May Christine Malicdan and Marie Morimoto

View past presentations, learn more about upcoming seminars, and register to attend on the NHGRI website.

Personalized Risk Assessment for Early Detection of Cancer
2023-12-21 09:00 - 10:00 | Virtual
Personalized Risk Assessment for Early Detection of Cancer
Thursday, December 21 | 9 a.m. ET | Online
Speaker: Dr. Nora Pashayan
Dr. Pashayan is a Professor of the Epidemiology of Aging and honorary Consultant in Public Health Medicine at the University of Cambridge. She is a cancer epidemiologist, a clinician with specialties in both Family Medicine and Public Health Medicine, and the Director of Training for the International Alliance for Cancer Early Detection. Dr. Pashayan’s primary research field is cancer early detection, risk stratification, and population-level screening. Her research focuses on understanding disease courses, evaluating screening strategies, and implementation of novel screening strategies.
This talk will introduce the concept of risk-stratified cancer screening and explore the essential considerations for implementation of such a screening program. Examples on integration and implementation will be drawn from the ongoing Canadian study, PERSPECTIVE I&I.
To learn more and register, visit the GGMC Educational Webinar Series page.
Please note: Registration is required for this webinar.

An Overview of Applied Machine Learning in Medicine at UNC
2024-01-04 12:00 - 13:00 | Virtual
An Overview of Applied Machine Learning in Medicine at UNC
Thursday, January 4 | 12-1 p.m. ET | 4th Floor Old Clinic Auditorium or Online
Speaker: Amanda Nelson, MD
Associate Professor of Medicine, UNC-Chapel Hill
A discussion on the application of AI tools to answer clinical questions around diagnosis, phenotyping, prognosis, and precision medicine using examples from investigators at UNC.

WebEx Information:
https://uncsom.webex.com/uncsom/j.php?MTID=m893f54367d9d2ac90bbac612e815bf88
Meeting number (access code): 2314 463 7243
Meeting password: [REDACTED]

Global Diversity, Local Context: The Role of Ancestry, Genetics, and Environment on Human Health
2024-01-11 15:00 - 16:00 | Virtual
Global Diversity, Local Context: The Role of Ancestry, Genetics, and Environment on Human Health
Thursday, January 11 | 3-4 p.m. ET | In-person & Virtual
Speaker: Genevieve Wojcik, PhD, MHS
Genetic Epidemiologist and Assistant Professor of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Dr. Wojcik’s research focuses on understanding the role of ancestry in genetic risk and developing solutions to address health inequities for diverse and admixed populations, as well as genetic susceptibility to infectious disease. Her most recent work explores the interaction of genetic ancestry and environment in admixed populations and downstream consequences for genetic risk prediction. Dr. Wojcik is a member of multiple NIH consortia, including the Population Architecture using Genomics and Epidemiology (PAGE) Study, the Clinical Genome Resource (ClinGen), and the Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium.
The Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research.
To learn more and register, visit the lecture series page.
Please note: Zoom registration is required for virtual attendees.

Duke Genomic Seminar Series
2024-02-08 14:00 - 15:00 | Duke Neurobiology Research Center, 311 Research Drive, Durham, NC, 27710, United States
A platform approach to develop and deploy CRISPR-Cas based experimental therapies for inborn errors of immunity in an academic/nonprofit setting
Thursday, February 8 | 2-3 p.m. ET | Bryan Neurobiology Research Building, Rm 103
Speaker: Fyodor Urnov, PhD
Professor of Molecular & Cellular Biology, University of California, Berkeley
Director of Technology & Translation, Innovative Genomics Institute
The vast majority of diseases clinically tractable by genome editing using current-state technology are not the targets of active preclinical or clinical development. Addressing this issue will require more involvement of the academic/nonprofit sector, but despite an existing charted path for advancing genome editing of specific cell types and tissues (such as T cells, hematopoietic stem cells, the liver, and the retina) to the clinic, there presently is only one open US IND for genome editing by an all-academic group. A key reason is that the current manufacturing, regulatory, and healthcare economics environment is not configured to maximize clinical impact of a technology like CRISPR-Cas. Under the framework that exists today, a pediatric patient newly diagnosed with a terminal illness such as a severe inborn error of immunity due to a never-before-seen but clinically editable mutation and a life expectancy of < 1 yr will have to wait ~3.5 years until a gene editing medicine is engineered, tested, and manufactured at an approximate total cost of $9m. An actionable path through this status quo is to develop and clinically derisk a dedicated nonclinical development path for use in academic/nonprofit settings in N=1/rare situations of dire medical need. From a technology standpoint, this will require comprehensive leveraging of the intrinsically platform nature of CRISPR-Cas gene editing. The Innovative Genomics Institute in close partnership with clinicians at UCSF and UCLA is developing such a platform focused on inborn errors of immunity, where ca 112,000 known patients suffering from 505 currently known diseases lack even a single open trial for genome editing open at the present time.
To learn more, visit Duke’s Genomic Seminar Series page.
Please note: This seminar series occurs quarterly with some events occurring virtually only and others in-person with streaming options.

Personalized Therapeutics: Clinical Reality and Future Challenges
2024-02-15 09:00 - 10:00 | Virtual
Personalized Therapeutics: Clinical Reality and Future Challenges
Thursday, February 15 | 9 a.m. ET | Virtual
Speaker: George P. Patrinos
Dr. Patrinos is a professor of pharmacogenomics and pharmaceutical biotechnology in the University of Patras’ (Greece) Department of Pharmacy, and holds adjunct professorships at Erasmus MC, Faculty of Medicine, Rotterdam (the Netherlands) and the United Arab Emirates University, College of Medicine, Department of Genetics and Genomics, Al-Ain (UAE). He also served for 12.5 years as full member and Greece’s National Representative in the CHMP Pharmacogenomics Working Party of the European Medicines Agency (EMA) and as Chair of the Global Genomic Medicine Collaborative (G2MC) since 2018.
About the Talk: This talk will provide a summary of the PREPARE and Em-HEART clinical studies in psychiatry and cardiology, and ethical and regulatory challenges in the field of pharmacogenomics.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required.

Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery – Current Status and the Path Forward
2024-02-15 13:00 - 14:00 | Virtual
Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery –
Current Status and the Path Forward
Thursday, February 15 | 1-2 p.m. ET | Virtual
Speakers: Paul C. Adams, MD, Professor, Division of Gastroenterology, Western University
Gail P. Jarvik, MD, PhD, Head and Professor, Division of Medical Genetics, University of Washington
Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD, Director, Liver Institute Northwest
In this webinar, speakers will discuss how knowledge about hereditary hemochromatosis (HH) has evolved since the discovery of the HFE gene in 1997, current opportunities for clinical and public health action to prevent disease, and future research priorities to advance case detection and reduce clinical complications from HH.
To learn more and register, visit the CDC events page.
Please note: Registration is required for this webinar.

Immune (check point) Related Adverse Events
2024-02-28 12:00 - 13:00 | Virtual
Immune (check point) Related Adverse Events
Wednesday, February 28 | 12 p.m. ET | Online
Speaker: Frances Collichio, MD, Professor of Medicine, UNC Chapel Hill
Dr. Collichio will review the common and uncommon side effects of immune check point inhibitors. She will also discuss the relatively new concept of delayed immune related events.
To learn more and register, visit the event webpage.
Please note: Registration is required for this webinar.

Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
2024-02-29 09:00 - 10:00 | Virtual
Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
Thursday, February 29 | 9 a.m. ET | Online
Speaker: Dr. Carlos Salomon Gallo
Dr. Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, NHMRC Investigator Fellow and is considered a worldwide authority on extracellular vesicles (EVs) biomarkers for complications of pregnancies and ovarian cancer (OC). In the last 10 years, Dr. Salomon’s primary research and commercialization activities have focused on the identification and validation of biomarkers, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer in investigating the release of EVs by the placenta and tumor cells and their utility as a biomarker for a wide range of pregnancy complications and OC.
This talk will cover the burgeoning field of EVs signaling holds the potential to revolutionize our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression, including tumor initiation, metastasis, and response to therapy. From the early stages of tumor development, tumor-derived EVs are detectable in the circulation.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

2024 ACMG Annual Clinical Genetics Meeting
2024-03-12 - 2024-03-16 | Metro Toronto Convention Center, 255 Front St W, Toronto, Ontario, M5V 2W6, Canada
2024 ACMG Annual Clinical Genetics Meeting
March 12-16 | Toronto, Canada
The ACMG sponsors an Annual Clinical Genetics Meeting and other events offering educational content in clinical genetics with the purpose of serving its members, other healthcare professionals and the public. Experience the transformation of medical genetics as treatments can increasingly be tailored with precision medicine and therapeutics.
To learn more and register, visit the meeting website.
Please note: Registration is required for in-person attendance and does not include session recordings. ACMG’s Digital Edition for recordings can be purchased separately and will be made available after the conference.

Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
2024-03-22 12:00 - 13:00 | Virtual
Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
Friday, March 22 | 12 p.m. ET | Hybrid: 321 MacNider Hall & Virtual
Speaker: Vardit Ravitsky, PhD
President and CEO, The Hastings Center
Senior Lecturer on Global Health and Social Medicine, Harvard Medical School
Professor, University of Montréal
Dr. Ravitsky will be speaking at the UNC Center for Bioethics’ Research Ethics Grand Rounds Merrimon Lecture. She is the President and CEO of The Hastings Center, an independent, nonpartisan bioethics research institute that is among the most prestigious bioethics and health policy institutes in the world. Dr. Ravitsky joins the Center from the University of Montreal where she was Professor at the Bioethics Program, School of Public Health. She is also a Senior Lecturer on Global Health and Social Medicine at Harvard Medical School. She received her PhD from Bar-Ilan University in Israel, her MA from the University of New Mexico, and her BA from the Sorbonne University in Paris, France. Dr. Ravitsky runs an active research program and holds several positions on advisory boards. Her research in bioethics focuses on ethical, legal, and social implications of genomics and assisted reproductive technologies, with an emphasis on emerging biotechnologies and their implications for women’s autonomy and for disability rights. She also studies the ethics of AI in biomedicine.
To learn more, visit the event webpage.
Zoom Webinar Link | Passcode: [REDACTED]

2024 Precision Medicine Tri-Conference
2024-03-26 - 2024-03-28 | Hilton San Diego Bayfront, 1 Park Boulevard, San Diego, CA, 92101, United States
2024 Precision Medicine Tri-Conference
March 26-28 | San Diego, CA
Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in precision medicine and precision health. Topics will include innovation and market access strategies for at-home diagnostics, liquid biopsy and advanced diagnostics for precision oncology, AI and digital tools, spatial biology and single-cell multiomics in advancing precision medicine and more.
To learn more and register, visit the conference website.
Please note: Registration is required for both in-person and virtual attendees.
